Hiperpigmentación Mucocutánea Asociada al Tratamiento con Hidroxiurea en un Paciente con Trombocitemia Esencial: Informe de Caso

Autor: Rodrigues, Daniela de Oliveira Werneck, Santos, Augusto Cézar Apolinário dos, Espósito, Thais Sette, Fonseca, Lucas Augusto Niess Soares, Mathiasi , Lucas Barra, Abreu, Nathália Chebli de, Costa , Monica de Albuquerque, Magalhães, Nathalia Noyma Sampaio, Fabri, Júlia Campos

Publikováno v: Revista Brasileira de Cancerologia; Vol. 69 No. 1 (2023): Jan./Feb./Mar.; e-042995
Revista Brasileira de Cancerologia; Vol. 69 Núm. 1 (2023): ene./feb./mar.; e-042995
Revista Brasileira de Cancerologia; v. 69 n. 1 (2023): jan./fev./mar.; e-042995
Revista Brasileira de Cancerologia
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA

Introduction: Mucocutaneous hyperpigmentation is a dermatological condition that may be related to chemotherapy treatments, such as therapies using hydroxyurea (HU). HU is a cytostatic drug widely used in myeloproliferative diseases and is the main l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::07dec4ffc842db3b25b043f7475f7a27
https://rbc.inca.gov.br/index.php/revista/article/view/2995